13F Data
13F filer · CIK 1442756

PFM Health Sciences, LP

SAN FRANCISCO, CA · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$1.2B
+$68.7M vs prior
Positions
98
New / sold out
35 / 20
Added / reduced
22 / 41
Turnover
36.6%
buys $414.5M · sells $528.0M
Top-10 weight
33.9%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewASCENDIS PHARMA A/S+233,171–+$62.2M
NewHUMANA INC+94,375–+$37.5M
NewMETTLER TOLEDO INTERNATIONAL+13,344–+$17.0M
NewMERCK & CO INC+127,118–+$16.3M
NewCYTOKINETICS INC+191,686–+$16.3M
NewLANTHEUS HLDGS INC+146,403–+$16.2M
NewCVSCVS HEALTH CORP+137,457–+$14.2M
AddedICON PUB LTD CO+78,982+137.4%+$13.7M
AddedUNITEDHEALTH GROUP INC+30,238+52.1%+$12.6M
NewGILEAD SCIENCES INC+90,858–+$11.5M
47 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outSPDR SERIES TRUSTPUT-455,300-100.0%$-58.2M
ReducedTENET HEALTHCARE CORP-271,995-68.2%$-50.9M
Sold outSELECT SECTOR SPDR TRCALL-238,900-100.0%$-35.0M
Sold outASCENDIS PHARMA A/S-152,034-100.0%$-34.8M
ReducedLLYELI LILLY & CO-26,504-40.3%$-31.8M
Sold outUNITED THERAPEUTICS CORP DELPUT-45,900-100.0%$-27.2M
ReducedPENUMBRA INC-79,558-56.9%$-25.1M
Sold outGLAUKOS CORP-215,685-100.0%$-23.2M
Sold outCENTESSA PHARMACEUTICALS PLC-528,224-100.0%$-21.0M
Sold outUNITED THERAPEUTICS CORP DELCALL-31,700-100.0%$-18.8M
51 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $4.8BQ3 2013: $4.2BQ4 2013: $5.1BQ1 2014: $5.5BQ2 2014: $5.0BQ3 2014: $4.3BQ4 2014: $4.3BQ1 2015: $3.8BQ2 2015: $4.1BQ3 2015: $3.7BQ4 2015: $3.3BQ1 2016: $3.2BQ2 2016: $3.3BQ3 2016: $3.4BQ4 2016: $3.5BQ1 2017: $4.0BQ2 2017: $3.7BQ3 2017: $5.1BQ4 2017: $4.2BQ1 2018: $4.9BQ2 2018: $6.4BQ3 2018: $6.8BQ4 2018: $3.8BQ1 2019: $4.5BQ2 2019: $5.3BQ3 2019: $3.4BQ4 2019: $2.1BQ1 2020: $1.2BQ2 2020: $1.9BQ3 2020: $2.2BQ4 2020: $2.8BQ1 2021: $3.3BQ2 2021: $3.2BQ3 2021: $3.4BQ4 2021: $2.9BQ1 2022: $2.7BQ2 2022: $2.6BQ3 2022: $2.8BQ4 2022: $2.8BQ1 2023: $2.3BQ2 2023: $2.6BQ3 2023: $2.1BQ4 2023: $1.7BQ1 2024: $2.1BQ2 2024: $2.0BQ3 2024: $1.8BQ4 2024: $1.6BQ1 2025: $1.4BQ2 2025: $1.2BQ3 2025: $1.3BQ4 2025: $1.0BQ1 2026: $1.1BQ2 2026: $1.2B
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1ASCENDIS PHARMA A/SORD SHS233,171$62.2M5.34%
2AXSOME THERAPEUTICS INC.COM219,596$53.8M4.61%
3LLYELI LILLY & CO39,258$47.1M4.04%
4JAZZ PHARMACEUTICALS PLCSHS USD160,768$38.7M3.32%
5HUMANA INCCOM94,375$37.5M3.22%
6UNITEDHEALTH GROUP INCCOM88,276$36.7M3.15%
7NEUROCRINE BIOSCIENCES INCCOM213,407$36.0M3.09%
8INHIBRX BIOSCIENCES INCCOM308,385$29.2M2.51%
9UNITED THERAPEUTICS CORP DELCOM49,991$27.1M2.32%
10REVOLUTION MEDICINES INCCOM143,222$26.8M2.30%
88 more rows. Subscribe for $29/month to see every row, download the data and use the API.